In terms of AD, there is evidence that S100B transgenic mice show enhanced susceptibility to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human β-amlyoid [144]. This evidence concerns the gene S100B and Alzheimer disease.